|
| AML (n = 88) | ALL (n = 56) |
| CD2 | 2 (2.3%) |
|
| CD3 | 2 (2.3%) |
|
| CD4 | 4 (4.5%) |
|
| CD5 | 2 (2.3%) |
|
| CD7 | 22 (25%) |
|
| CD19 | 10 (13.4%) |
|
| CD22 | 8 (9.1%) |
|
| CD10 | 0 (0%) |
|
| CD13 |
| 22 (39.3%) |
| CD33 |
| 4 (7.1%) |
| CD14 |
| 0 (0%) |
| CD15 |
| 0 (0%) |